These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38406851)

  • 1. Dl-3-n-Butylphthalide Alleviates Secondary Brain Damage and Improves Working Memory After Stroke in Cynomolgus Monkeys.
    Jiang Z; Wei J; Liang J; Huang W; Ouyang F; Chen C; Li P; Cao S; Cai Y; Li J; Huang B; Zeng J; Chen Y
    Stroke; 2024 Mar; 55(3):725-734. PubMed ID: 38406851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DL-3-n-Butylphthalide Ameliorates Post-stroke Emotional Disorders by Suppressing Neuroinflammation and PANoptosis.
    Cui Y; Hu Z; Wang L; Zhu B; Deng L; Zhang H; Wang X
    Neurochem Res; 2024 Aug; 49(8):2215-2227. PubMed ID: 38834844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal loss without amyloid-β deposits in the thalamus and hippocampus in the late period after middle cerebral artery occlusion in cynomolgus monkeys.
    Ouyang F; Chen X; Chen Y; Liang J; Chen Y; Lu T; Huang W; Zeng J
    Brain Pathol; 2020 Jan; 30(1):165-178. PubMed ID: 31278793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats.
    Zhang H; Wang L; Zhu B; Yang Y; Cai C; Wang X; Deng L; He B; Cui Y; Zhou W
    Eur J Pharmacol; 2023 Jul; 951():175801. PubMed ID: 37207969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dl-3-n-butylphthalide improves stroke outcomes after focal ischemic stroke in mouse model by inhibiting the pyroptosis-regulated cell death and ameliorating neuroinflammation.
    Ge M; Jin L; Cui C; Han Y; Li H; Gao X; Li G; Yu H; Zhang B
    Eur J Pharmacol; 2024 Jul; 974():176593. PubMed ID: 38636800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dl-3-N-butylphthalide attenuates ischemic reperfusion injury by improving the function of cerebral artery and circulation.
    Qin C; Zhou P; Wang L; Mamtilahun M; Li W; Zhang Z; Yang GY; Wang Y
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):2011-2021. PubMed ID: 29762050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization.
    Li F; Ma Q; Zhao H; Wang R; Tao Z; Fan Z; Zhang S; Li G; Luo Y
    Metab Brain Dis; 2018 Dec; 33(6):1995-2003. PubMed ID: 30117100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
    Liu XG; Feng YP
    Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DL-3-n-Butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment.
    Zhang L; Yu WH; Wang YX; Wang C; Zhao F; Qi W; Chan WM; Huang Y; Wai MS; Dong J; Yew DT
    Curr Neurovasc Res; 2012 Aug; 9(3):167-75. PubMed ID: 22621233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke.
    Guan Y; Li P; Liu Y; Guo L; Wu Q; Cheng Y
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress.
    Zhang H; Wang L; Yang Y; Cai C; Wang X; Deng L; He B; Zhou W; Cui Y
    Front Pharmacol; 2022; 13():987293. PubMed ID: 36712684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of dl-3n-butylphthalide on the expression of VEGF and bFGF in transient middle cerebral artery occlusion rats].
    Cao WY; Deji QZ; Li QF; He L; Zhou D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):403-7. PubMed ID: 19626991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol of End-PSCI trial: a multicenter, randomized controlled trial to evaluate the effects of DL-3-n-butylphthalide on delayed-onset post stroke cognitive impairment.
    Liu Z; Lu W; Gao L; Guo X; Liu J; Gao F; Huo K; Wang J; Qu Q
    BMC Neurol; 2022 Nov; 22(1):435. PubMed ID: 36384493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats.
    Peng Y; Xu S; Chen G; Wang L; Feng Y; Wang X
    J Pharmacol Exp Ther; 2007 Jun; 321(3):902-10. PubMed ID: 17374747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
    Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia.
    Zhang Y; Wang L; Li J; Wang XL
    J Pharmacol Exp Ther; 2006 Jun; 317(3):973-9. PubMed ID: 16527903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study.
    Chen D; Yin Y; Shi J; Yang F; Wang K; Zhao F; Li W; Li B
    BMC Neurol; 2020 May; 20(1):212. PubMed ID: 32456617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of DL-3-n-butylphthalide in the treatment of poststroke cognitive impairment and its associated predictive cytokines: a systematic review and meta-analysis.
    Wang Z; Wang J; Yun J; Song J; Chen Q; Wang D; Ren C
    BMC Pharmacol Toxicol; 2024 Sep; 25(1):65. PubMed ID: 39334406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress.
    Wang BN; Wu CB; Chen ZM; Zheng PP; Liu YQ; Xiong J; Xu JY; Li PF; Mamun AA; Ye LB; Zheng ZL; Wu YQ; Xiao J; Wang J
    Acta Pharmacol Sin; 2021 Mar; 42(3):347-360. PubMed ID: 33462377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DL-3-n-butylphthalide Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting Mitochondrial Omi/HtrA2-Mediated Apoptosis.
    Huang S; He Q; Sun X; Qu Y; Abuduxukuer R; Ren J; Zhang K; Yang Y; Guo ZN
    Curr Neurovasc Res; 2023; 20(1):101-111. PubMed ID: 36852812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.